Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Renal Pelvic and Ureteral Neoplasms.


Clinical Trial Description

By enrolling patients with unresectable Renal Pelvic and Ureteral Neoplasms adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of percutaneous IRE for unresectable Renal Pelvic and Ureteral Neoplasms. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02430779
Study type Interventional
Source Fuda Cancer Hospital, Guangzhou
Contact
Status Completed
Phase N/A
Start date January 1, 2015
Completion date January 1, 2021